Technology News and Research

RSS

Researchers develop Bergen Work Addiction Scale

Researchers from Norway and the United Kingdom have developed a new instrument to measure work addiction: The Bergen Work Addiction Scale. The new instrument is based on core elements of addiction that are recognised as diagnostic criteria for several addictions.

24 Apr 2012

Health Management first quarter net revenue increases 18.4% to $1.485B

Health Management Associates, Inc. today announced its consolidated financial results for the first quarter ended March 31, 2012.

24 Apr 2012

FDA issues draft guidelines on approval process for use of nanoparticles in food and cosmetics

The United States Food and Drugs Administraton (FDA) has proposed that food companies that want to use tiny engineered particles called nanoparticles in their packaging may have to provide extra testing data to show the products are safe.

23 Apr 2012

Cosmetic contact lens on the rise among Malaysians

Malaysia’s beauty contact lens market is fast catching up with developed countries in the region such as Singapore, Taiwan and South Korea, which are all exhibiting similar upward trending in the sales of these beauty accessories. GfK retail tracking reported Malaysians spending a total of nearly USD 55 million on contact lenses in 2011, of which 28 percent was contributed by the beauty segment.

23 Apr 2012

Nephros granted rights to market products based on Medica's Medisulfone ultrafiltration technology

Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and advanced water purification solutions, today announced that the company has entered into a strategic license and supply agreement with Medica S.p.A.

23 Apr 2012

Kansas to implement eClinicalWorks EMR system

eClinicalWorks, a market leader in ambulatory clinical systems, announces that Meritas Health Corporation has chosen eClinicalWorks as its electronic medical records (EMR) system. Meritas Health Corporation is a multi-specialty group in Kansas City, Mo., with 72 employed physicians.

23 Apr 2012

Medgenics seeks FDA Orphan Drug Designation for INFRADURE to treat hepatitis D

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.

23 Apr 2012

Aggredyne closes $3 million Series A convertible preferred stock financing

Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.

23 Apr 2012

Method to manufacture cartilage from human embryonic stem cells

BioTime, Inc. and its wholly owned subsidiary OrthoCyte Corporation reported today a means of manufacturing cartilage from human embryonic stem cells that is suited for industrial scale-up of a product for the treatment of osteoarthritis.

23 Apr 2012

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

23 Apr 2012

RVX-208 molecule increases apolipoprotein A-I production

Resverlogix Corp. today announces the "Mechanism of Action" (MoA) by which RVX-208 increases apolipoprotein A-I (ApoA-I) production.

23 Apr 2012

New titanium vertebral body replacement device from ulrich medical

ulrich medical USA, Inc., today announced the release of the Omni VBR Implant System, a new titanium vertebral body replacement device that is intended for use in the thoracic and lumbar spine (T1-L5) to replace a collapsed, damaged or unstable vertebral body due to tumor or trauma.

23 Apr 2012

Cancer, genetic screenings under scrutiny

Various news outlets covered issues around cancer screening, diagnosis and treatment.

23 Apr 2012

Enrollment complete in REPRISE I clinical trial for Lotus Aortic Valve System

Boston Scientific Corporation announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release.

23 Apr 2012

Healthways announces acquisition of Ascentia Health Care Solutions

Ben R. Leedle, Jr., president and chief executive officer of Healthways, announced that the Company has acquired Ascentia Health Care Solutions, a Philadelphia area based company whose business is designed to support and promote population health management, patient centered programs, payer strategies and physician practice enhancement programs.

23 Apr 2012